相关实验视频

Updated: Jan 7, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

636

纳米增强型饮食:促进与代谢功能障碍相关的脂肪性肝病 (MASLD) - - 综述

Yedi Herdiana1

  • 1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia.

Diabetes, metabolic syndrome and obesity : targets and therapy
|December 29, 2025
PubMed
概括

基于纳米的营养递送系统通过提高营养药的生物可用性来治疗与代谢功能障碍相关的脂肪性肝病 (MASLD). 进一步研究纳米毒性和可扩展性是需要临床翻译.

关键词:
生物活性输送系统生物活性输送系统生物可用性 生物可用性纳米技术是纳米技术.营养保健品 营养保健品氧化应激是一种氧化应激.有针对性的营养物质输送.

更多相关视频

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.6K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.8K

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165